MIPS 2022 Measures for the Allergy and Immunology

Each performance category accounts for a particular percentage of the overall score, which determines how much payment adjustment a clinician will receive for the following MIPS year’s performance.

The rules and regulations relating to each category also change or are updated every year.

So today, we will be discussing the MIPS Quality Measures linked to Allergy and Immunology.

MIPS Reporting Measures for Allergy and Immunology Specialty

Below, we will be providing brief explanations of the measures that specifically deal with the Allergy and Immunology specialty for the MIPS 2022 evaluation.

MIPS 2022 Quality Measures for Allergy and Immunology

This category makes up 30% of the final score, and participants have to report six measures out of the available ones. At least one of the six measures has to be an outcome-based or high priority measure, and all of them have to be reported for 12 months.

This category deals with 12 to 20 years old adolescents who went to a primary healthcare provider for the following reasons:

  • The documentation of their current status and why they are using tobacco
  • And if they are a regular user of tobacco or a smoker, then helping them quit the addiction
2022 MIPS Measure no. 110
Preventive Care and Early Detection: Immunization Against Influenza This category is for six months or older patients who went to a clinic to get an influenza immunization or have shown an old receipt of previously getting immunized. It needs to be done anytime from the 1st of October to
the 31st of March.
2022 MIPS Measure no. 111
Pneumococcal Vaccination Status of Older Adults It is for the 66 or older patients who have ever gotten the dose of the pneumococcal vaccine.
2022 MIPS Measure no. 111
Pneumococcal Vaccination Status of Older Adults It is for the 66 or older patients who have ever gotten the dose of the pneumococcal vaccine.
2022 MIPS Measure no. 130
Documentation of Current Medications in the Medical Record of the Patient It is a high priority measure, and it is for patients of age 18 or more who take multiple medications. Their doctor must attest to all their medication and document it in their medical file using the means available
during their visit.
2022 MIPS Measure no. 130
Documentation of Current Medications in the Medical Record of the Patient It is a high priority measure, and it is for patients of age 18 or more who take multiple medications. Their doctor must attest to all their medication and document it in their medical file using the means available
during their visit.
2022 MIPS Measure no. 226
Preventive Care and Early Detection: Checking for Tobacco Use and Intervention for Ceasing It is for patients aged 18 or more who:

  • Got tested for smoking once or twice in the past 12 months
  • And if they were regular smokers, they had an intervention to help them stop
2022 MIPS Measure no. 238
Use of High-Risk Medications in the Elderly It is a high-priority measure for patients 65 and older who use at least two high-risk drugs.
2022 MIPS Measure no. 317
Preventive Care and Early Detection: Checking for High Blood Pressure and Follow-Up Documentation This category is for 18 and older patients who got check-ups for high blood pressure during the measurement period. If their result was pre-hypertensive or hypertensive, they had to come for a follow-up that got
documented.
2022 MIPS Measure no. 331
Adult Sinusitis: Treatment of Acute Viral Sinusitis with Antibiotics (For Overuse) This is a high priority measure and it is for patients aged 18 or more, who got diagnosed with acute viral sinusitis and were given an antibiotic within 10 days of showing symptoms.
2022 MIPS measure no. 332
Adult Sinusitis: Suitable Option of Antibiotic: Patients with Acute Bacterial Sinusitis who were prescribed Amoxicillin with or without Clavulanate (For Appropriate Use) This is a high priority measure and it is for patients aged 18 or more, who got diagnosed with acute bacterial sinusitis and were prescribed amoxicillin for treatment. Amoxicillin could be with or without clavulanate.
2022 MIPS Measure no. 338
Viral Load Suppression for HIV It is a high priority measure for patients who have been diagnosed with HIV, regardless of age. And have had an HIV viral load of fewer than 200 copies per mL at their last viral load test during the current measurement
year.
2022 MIPS Measure no. 340
Medical Visit Frequency of Patients Diagnosed with HIV It is a high priority measure for patients diagnosed with HIV, no matter their age. They must have had a medical visit every six months within the last 24-month measurement period, with a minimum of 60 days between each
visit.
2022 MIPS Measure no. 374
Receiving Patient’s Information from the Specialist and Completing the Referral Cycle It is a high priority measure for the patients who come to a new healthcare provider with a referral from their old one. Regardless of their age, the new provider will receive information about them from the previous
one.
2022 MIPS Measure no. 398
Optimal Management of Asthma It is a high priority measure and a cumulative evaluation of adult and pediatric patients with well-controlled asthma that is not at the risk of becoming worse. This was determined by one of the three age-appropriate
patient-reported measure outcome (PROM) tools.
2022 MIPS Measure no. 402
Harmful Use of Tobacco in Adolescents and Getting Them to Quit This category deals with 12 to 20 years old adolescents who went to a primary healthcare provider for the following reasons:

  • The documentation of their current status and why they are using tobacco
  • And if they are a regular user of tobacco or a smoker, then helping them quit the addiction

MIPS 2022 Measures, MIPS 2022 Reporting, MIPS incentive program, MIPS 2022, 2022 MIPS measures, MIPS Quality Measures, MIPS 2022 evaluation

MIPS 2022 Promoting Interoperability (PI) Measures for Allergy and Immunology

In MIPS 2022 reporting, this category makes up 25% of the final score. All participants have to submit data for the measures for a minimum of 90 days. If you are using EHR Technology of the 2015 edition, it must be in place by October 3, 2021.

In Case of Exception 

If you are eligible for an exception from this category, then its 25% will be reweighed to the Quality performance category, making it hold 65% of the total score.

Reporting Measures for Allergy and Immunology Specialty

The measures of this performance category relevant to Allergy and Immunology are:

  • E-Prescribing
  • Give Patients Electronic Access to Information Regarding Their Health
  • Reporting Data from the Clinical Registry
  • Reporting
  • Data from the Immunization Registry
  • Public Health Registry Data Reporting
  • Report Data Regarding Syndromic Monitoring
  • Electronic Case Reporting (ECR)
  • Send Health Information to Support Electronic Referral Loops. (Option no. 1)
  • Support Electronic Referral Loops by Receiving and Reconciling Health Information (Option no. 1)
  • Health Information Exchange (HIE) Bi-Directional Exchange (Option no. 2)
  • The query of Prescription Drug Monitoring Program (PDMP) (optional)

MIPS 2022 Measures, MIPS 2022 Reporting, MIPS incentive program, MIPS 2022, 2022 MIPS measures, MIPS Quality Measures, MIPS 2022 evaluation

MIPS 2022 Improvement Activities (IA) Measures for Allergy and Immunology

In 2022, this category makes up 15% of the total MIPS score. Participants need to attest that they completed either two high-weighted or four medium-weighted activities for a minimum of 90 days.

Group Participation and Exceptions Regarding Allergy and Immunology Category

There are a few reasons you can get an exception from reporting the set number of activities. Such as,

  • If you are taking part in the 2022 MIPS evaluation as part of a group and it has 15 or fewer members
  • If you are in a rural area with a health professional shortage

In these cases, you can attest to one high-weighted or two medium-weighted activities for a minimum of 90 days.

Also, a group can attest to an activity if at least 50% of the clinicians in the group perform it for a continuous 90-day period in the same performance year.

MIPS 2022 Measures, MIPS 2022 Reporting, MIPS incentive program, MIPS 2022, 2022 MIPS measures, MIPS Quality Measures, MIPS 2022 evaluation

Reporting Measures

There are over 100 measures to choose from, and here are a few options relevant to the Allergy and Immunology specialty.

  • IA_EPA_3 – Collecting and using data related to patient experience and satisfaction to improve access (medium-weighted)
  • IA_CC_8 – Implement enhancements of documentation to improve practice and process (medium-weighted).
  • IA_CC_2 – Execution of improvements to get faster communication of test results (medium-weighted)
  • IA_AHE_1 – Improve participation of Medicaid and other underprivileged communities (high-weighted)
  • IA_BE_14 – Improve interactions with patients and their families to help better the care system (high-weighted)

Source link

Comments are closed.